Based on the patient characteristics of an elderly AF patient with renal impairment Dr. John W. Eikelboom will review existing data from multiple sources including RE-LY subgroup data to support the dabigatran treatment decision for this patient
Based on the patient characteristics of an AF patient with cardiovascular comorbidities Dr. John W. Eikelboom will review existing data from multiple sources including RE-LY subgroup data, GLORIA AF and RE-DUAL PCI to support the dabigatran treatment decision for this patient
This is a video showing the MOA of thrombin inhibition on intracranial haemorrhage. It shows how dabigatran, a thrombin inhibitor minimises thrombin mediated damage and preserves the brain barrier, thereby minimising intracranial hemorage. It showcases the RE-LY trial as well as the confirmation of the trial by RWE.
Interview with Oscar Oseroff, Secretary General: World Society of Arrhythmias. In this interview he invites fellow friends and colleagues to join him at the World Congress of Arrhythmias (WSA 2019) in Buenos Aires, Argentina between 2nd – 4th of November 2019. Filming took place at the World Society of Arrhythmias stand at ESC 2019, Paris, […]
The results from the full cohort analysis of the REVERSE-AD study provide compelling evidence for idarucizumab’s ability to immediately, completely and sustainably reverse the anticoagulant effect of dabigatran. This video summarizes the key results of the RE-VERSE AD study and shows the importance of specific reversibility in the context of anticoagulation
Summary of GLORIA-AF Final Phase II: Two-year safety and effectiveness of dabigatran in patients with atrial fibrillation (summarized by Prof Gregory Lip). An educational video summarizing data presented at EHRA, Barcelona 2018.
The series of infographic animations communicate the consistency of results, how RWE supports the favorable safety profile and the importance of RWE evidence. From Clinical Studies to RWE This infographic animation communicates the consistency of results, how RWE supports the favourable safety profile and the importance of RWE evidence. Safety proven by RWE This infographic […]